Ceva sponsors Cattle Professional Foot Trimming course

Ceva Animal Health, the manufacturer of Ketofen®, is sponsoring a Professional Foot Trimming course for cattle.

The four-day course, which is organised by Embryonics, will take place in Cheshire and runs from Monday 24 February to Thursday 27 February. It will cover the five-step Dutch method of foot trimming, the most successful tried and tested method of trimming, to help reduce the incidence of lameness in the herd. Course tutors include John Dawson MRCVS BVMS CertCHP Dip Cattle footcare and a Ceva representative will also present information on how the management of pain and inflammation fits into a comprehensive lameness treatment programme. The practical course is a recognised route to becoming a NACFT (National Association of Cattle Foot Trimmers) licensed foot trimmer.

Peter Keyte, ruminant business unit manager at Ceva, comments: “We would like to encourage livestock vets, farmers and professional foot trimmers to work more closely together, as a team, to help prevent lameness in cattle. We are therefore delighted to be supporting the industry by sponsoring this course, which will help raise welfare standards across the industry.”

“The Professional Foot Trimming course is ideal for individuals wishing to become licensed foot trimmers and we are very grateful for Ceva’s support,” adds Embryonics’ director, John Dawson.

For further information on the Professional Foot Trimming course, please visit www.embryonicsltd.co.uk.

Ends

Notes to editors
Ceva Animal Health is a subsidiary of Ceva Santé Animale, a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, pigs and poultry. For more information visit www.ceva.co.uk.

Ketofen® 10% solution for injection contains ketoprofen 100 mg/ml and benzyl alcohol 10 mg/ml.

In cattle, Ketofen 10% is indicated for:
• The supportive treatment of parturient paresis associated with calving;
• Reducing the pyrexia and distress associated with bacterial respiratory disease when used in conjunction with antimicrobial therapy as appropriate;
• Improving the recovery rate in acute clinical mastitis, including acute endotoxin mastitis, caused by gram negative micro-organisms, in conjunction with antimicrobial therapy;
• Reducing oedema of the udder associated with calving;
• Reducing pain associated with lameness

In horses, Ketofen 10% is indicated for:
• The alleviation of inflammation and pain associated with musculoskeletal disorders;
• The alleviation of visceral pain associated with colic.

In pigs, Ketofen 10% is indicated for:
• Reducing the pyrexia and respiratory rate associated with bacterial or viral respiratory disease when used in conjunction with antimicrobial therapy as appropriate;
• The supportive treatment of Mastitis Metritis Agalactia Syndrome in sows, in conjunction with antimicrobial therapy as appropriate.

LEGAL CATEGORY: POM-V UK POM IE

Use medicines responsibly (www.noah.co.uk/responsible)